Publications by authors named "Jakob Eberhard"

Claim this Profile
R
Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer.
Alexandra Petersson, Maja Svensson, Sofie Olsson Hau, Rebecka Bergström, Johan Lindberg, Jakob Eberhard

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The bile duct and liver cancer: ON-treatment surveillance of tumor evolution and response to systemic treatment (BILLIONSTARS) study.
Philip Falk, Sofie Olsson Hau, Hedda Jacobsen, Jakob Eberhard, Caroline Williamsson

BMC Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life for patients with advanced gastrointestinal cancer randomised to early specialised home-based palliative care: the ALLAN trial.
Anders Bojesson, Eva Brun, Jakob Eberhard, Mikael Segerlantz

Br J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature.
Mef Nilbert, Jakob Eberhard, Jenny Engdahl Severin, Marcus Edelhamre, Filip Torle

Acta Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature.
Mef Nilbert, Jakob Eberhard, Jenny Engdahl Severin, Marcus Edelhamre, Filip Torle

Acta Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study.
Sofie Olsson Hau, Maja Svensson, Alexandra Petersson, Jakob Eberhard, Karin Jirström

BMC Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study.
Sofie Olsson Hau, Caroline Williamsson, Bodil Andersson, Jakob Eberhard, Karin Jirström

BMC Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of Specialized Palliative Care with Oncological Treatment in Patients with Advanced Pancreatic Cancer.
Anders Ekström, Eva Brun, Jakob Eberhard, Mikael Segerlantz

J Pancreat Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis.
Christina Siesing, Alexandra Petersson, Thora Ulfarsdottir, Subhayan Chattopadhyay, Björn Nodin, Jakob Eberhard

Mod Pathol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer.
Philip Falk, Mira Severin, Åke Berglund, Marianne G Guren, Eva Hofsli, Jakob Eberhard

Cancer Treat Res Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer.
Alexandra Petersson, Natalie Andersson, Sofie Olsson Hau, Jakob Eberhard, Jenny Karlsson

Mol Cancer Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors.
Henrik Ekedahl, Sigrid Isaksson, Olof Ståhl, Karolina Bogefors, Patrik Romerius, Jakob Eberhard

BMC Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer.
Sofie Olsson Hau, Sara Wahlin, Sophie Cervin, Vilgot Falk, Björn Nodin, Jakob Eberhard

J Pathol Clin Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer.
Anders Ekström, Eva Brun, Jakob Eberhard, Mikael Segerlantz

Acta Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations.
Nadia Emad Lotfi Amin, Torben Frøstrup Hansen, Eva Fernebro, John Ploen, Jakob Eberhard

Int J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumors.
Halla Vidarsdottir, Christina Siesing, Björn Nodin, Per Jönsson, Jakob Eberhard

J Surg Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas.
Margareta Heby, Emelie Karnevi, Jacob Elebro, Björn Nodin, Jakob Eberhard

Sci Rep· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy, host response and molecular dynamics in periampullary cancer: the CHAMP study.
Sofie Olsson Hau, Alexandra Petersson, Björn Nodin, Emelie Karnevi, Karolina Boman, Jakob Eberhard

BMC Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trial.
David Borg, Jan Sundberg, Eva Brun, Elisabeth Kjellén, Kristoffer Petersson, Jakob Eberhard

Acta Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition.
Jonna Berntsson, Jakob Eberhard, Björn Nodin, Karin Leandersson, Anna H Larsson

Oncoimmunology· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome.
Sebastian Lundgren, Sofie Olsson Hau, Jacob Elebro, Margareta Heby, Emelie Karnevi, Jakob Eberhard

JCO Precis Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis.
Jonna Berntsson, Jakob Eberhard, Björn Nodin, Karin Leandersson, Anna H Larsson

Oncoimmunology· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma.
Margareta Heby, Sebastian Lundgren, Björn Nodin, Jacob Elebro, Jakob Eberhard

J Transl Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of poor performance status after resection of colorectal liver metastases.
Peter Strandberg Holka, Sam Eriksson, Jakob Eberhard, Magnus Bergenfeldt, Gert Lindell

World J Surg Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification.
Emelie Karnevi, Liv Ben Dror, Adil Mardinoglu, Jacob Elebro, Margareta Heby, Jakob Eberhard

Oncotarget· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis